Robert L Hollis (R L Hollis)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Endometrial Cancer

Tyrosine Kinase

Endoplasmic Reticulum

Top Venues

British journal of cancer

JNCI cancer spectrum

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna M Porter, Iona Mcfarlane, Clare Bartos, Michael Churchman, James May, C Simon Herrington, Kathryn C Connolly, Neil Aj Ryan, Robert L Hollis
The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype-specific. JNCI cancer spectrum (2024)
Joanna M Porter, Iona McFarlane, Clare Bartos, Michael Churchman, James May, C Simon Herrington, Kathryn C Connolly, Neil A J Ryan, Robert L Hollis
The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific. JNCI cancer spectrum 8 (4) (2024)
Joanna M Porter, Iona McFarlane, Clare Bartos, Michael Churchman, James May, C Simon Herrington, Kathryn C Connolly, Neil A J Ryan, Robert L Hollis
The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific. JNCI cancer spectrum 8 (4) (2024)
C. Simon Herrington, Ailsa J Oswald, Lorna J Stillie, Ian Croy, Michael Churchman, Robert L Hollis
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma. British journal of cancer (2023)
C. Simon Herrington, Ailsa J Oswald, Lorna J Stillie, Ian Croy, Michael Churchman, Robert L Hollis
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma. British journal of cancer 130 (2) (2023)
C. Simon Herrington, Ailsa J Oswald, Lorna J Stillie, Ian Croy, Michael Churchman, Robert L Hollis
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma. British journal of cancer 130 (2) (2023)
C. Simon Herrington, Ailsa J Oswald, Lorna J Stillie, Ian Croy, Michael Churchman, Robert L Hollis
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma. British journal of cancer 130 (2) (2023)
C. Simon Herrington, Ailsa J Oswald, Lorna J Stillie, Ian Croy, Michael Churchman, Robert L Hollis
Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma. British journal of cancer 130 (2) (2023)
Robert L Hollis, Alison M Meynert, Caroline O Michie, Tzyvia Rye, Michael Churchman, Amelia Hallas-Potts, Ian Croy, W Glenn McCluggage, Alistair R W Williams, Clare Bartos, Yasushi Iida, Aikou Okamoto, Brian Dougherty, J Carl Barrett, Ruth March, Athena Matakidou, Patricia Roxburgh, Colin A Semple, D Paul Harkin, Richard Kennedy, C. Simon Herrington, Charlie Gourley
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Robert L Hollis, Ian Croy, Michael Churchman, Clare Bartos, Tzyvia Rye, Charlie Gourley, C. Simon Herrington
Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma. British journal of cancer 127 (6) (2022)
Ailith Ewing, Alison M Meynert, Michael Churchman, Graeme R Grimes, Robert L Hollis, C. Simon Herrington, Tzyvia Rye, Clare Bartos, Ian Croy, Michelle Ferguson, Mairi Lennie, Trevor McGoldrick, Neil McPhail, Nadeem Siddiqui, Suzanne Dowson, Rosalind M Glasspool, Melanie Mackean, Fiona Nussey, Brian McDade, Darren Ennis, Lynn McMahon, Athena Matakidou, Brian Dougherty, Ruth March, J Carl Barrett, Iain A McNeish, null null, Andrew V Biankin, Patricia Roxburgh, Charlie Gourley, Colin A Semple
Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Robert L Hollis, Lorna J Stillie, Samantha Hopkins, Clare Bartos, Michael Churchman, Tzyvia Rye, Fiona Nussey, Scott Fegan, Rachel Nirsimloo, Gareth J Inman, C. Simon Herrington, Charlie Gourley
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma. Cancers 13 (22) (2021)
Robert L Hollis, Barbara Stanley, John P Thomson, Michael Churchman, Ian Croy, Tzyvia Rye, Clare Bartos, Fiona Nussey, Melanie Mackean, Alison M Meynert, Colin A Semple, Charlie Gourley, C. Simon Herrington
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification. NPJ precision oncology 5 (1) (2021)
Robert L Hollis, John P Thomson, Barbara Stanley, Michael Churchman, Alison M Meynert, Tzyvia Rye, Clare Bartos, Yasushi Iida, Ian Croy, Melanie Mackean, Fiona Nussey, Aikou Okamoto, Colin A Semple, Charlie Gourley, C. Simon Herrington
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome. Nature communications 11 (1) (2020)
A Irodi, T Rye, K Herbert, M Churchman, C Bartos, M Mackean, F Nussey, C S Herrington, C Gourley, Robert L Hollis
Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data. BJOG : an international journal of obstetrics and gynaecology 127 (11) (2020)
Simon P Langdon, C Simon Herrington, Robert L Hollis, Charlie Gourley
Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer. Cancers 12 (6) (2020)
Miriam K Gomez, Giuditta Illuzzi, Carlota Colomer, Michael Churchman, Robert L Hollis, Mark J O'Connor, Charlie Gourley, Elisabetta Leo, David W Melton
Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer Cells. Cancers 12 (6) (2020)
Robert L Hollis, Michael Churchman, Caroline O Michie, Tzyvia Rye, Laura Knight, Andrena McCavigan, Timothy Perren, Alistair R W Williams, W Glenn McCluggage, Richard S Kaplan, Gordon C Jayson, Amit Oza, D Paul Harkin, C Simon Herrington, Richard Kennedy, Charlie Gourley
High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. Cancer 125 (16) (2019)